OnKure Therapeutics, Inc. OKUR Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s total liabilities?
- OnKure Therapeutics, Inc. (OKUR) reported total liabilities of $14.34M in Q1 2026.
- How has OnKure Therapeutics, Inc.'s total liabilities changed year-over-year?
- OnKure Therapeutics, Inc.'s total liabilities increased by 55.3% year-over-year, from $9.23M to $14.34M.
- What is the long-term trend for OnKure Therapeutics, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), OnKure Therapeutics, Inc.'s total liabilities has grown at a 5.1% compound annual growth rate (CAGR), from $4.62M to $5.93M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.